SCHEMBL6000496

SCHEMBL6000496

CCCC(CCC)c1ccc(Cn2cc(-c3csc(COc4ccc(C(=O)O)cc4)n3)c3ccccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
CA12 O43570 5/20 0.41
CA1 P00915 5/20 0.41
CA9 Q16790 5/20 0.41
CA2 P00918 4/20 0.41
F2RL3 Q96RI0 1/20 0.40
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX5 P09917 2/20 0.38
CHRM1 P11229 1/20 0.38
AHR P35869 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
NCOR2 Q9Y618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000787 0.84 CA12 (0.44) CA12CA1CA9CA2CHRM1
SCHEMBL6000631 0.81 ROCK2 (0.44) CA12CA1CA9CA2F2RL3
SCHEMBL5999945 0.80 CA12 (0.39) CA12CA1CA9CA2F2RL3
SCHEMBL6000162 0.80 CA12 (0.41) CA12CA1CA9CA2F2RL3
SCHEMBL6000642 0.79 PTPN2 (0.61) PTPN2PTPN1KDM4EALOX5RXRA
SCHEMBL6000946 0.79 PTPN2 (0.61) PTPN2PTPN1KDM4EALOX5RXRA
SCHEMBL6000044 0.79 CA12 (0.41) PTPN2PTPN1CA12CA1CA9
SCHEMBL6000526 0.79 CA12 (0.39) PTPN2PTPN1CA12CA1CA9
SCHEMBL5999795 0.76 RXRA (0.43) PTPN2PTPN1ALOX5MAPTRXRA
SCHEMBL6000216 0.74 PTPN2 (0.55) PTPN2PTPN1KDM4EMEN1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 PTPN2 11/4885PTPN1 2/4885CA12 2910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.